ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation

Shaji Kumar; Zihan Wei; Michael A Thompson; null et al; Aurora Complex General Surgical Oncology Faculty

doi:10.1200/JCO.2021.39.15_suppl.TPS8052

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation

Shaji Kumar, Zihan Wei, Michael A Thompson, et al, Aurora Complex General Surgical Oncology Faculty

Advocate Aurora Health

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	Journal of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS8052
Status	Published - May 1 2021

Access to Document

10.1200/JCO.2021.39.15_suppl.TPS8052License: Unspecified

Cite this

Kumar, S., Wei, Z., Thompson, M. A., et al, & Complex General Surgical Oncology Faculty, A. (2021). ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS8052

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. / Kumar, Shaji; Wei, Zihan; Thompson, Michael A et al.
In: Journal of Clinical Oncology, 01.05.2021.

Research output: Contribution to journal › Meeting abstract

Kumar, S, Wei, Z, Thompson, MA, et al & Complex General Surgical Oncology Faculty, A 2021, 'ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS8052

Kumar S, Wei Z, Thompson MA, et al, Complex General Surgical Oncology Faculty A. ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. Journal of Clinical Oncology. 2021 May 1. doi: 10.1200/JCO.2021.39.15_suppl.TPS8052

@article{b21e6662f0df46db8401abaea85f8d8d,

title = "ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation",

author = "Shaji Kumar and Zihan Wei and Thompson, {Michael A} and {et al} and {Complex General Surgical Oncology Faculty}, Aurora",

note = "Kumar S, Wei Z, Thompson MA, et al. ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. Journal of clinical oncology. 2021;39:TPS8052-TPS8052.",

year = "2021",

month = may,

day = "1",

doi = "10.1200/JCO.2021.39.15_suppl.TPS8052",

language = "American English",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation

AU - Kumar, Shaji

AU - Wei, Zihan

AU - Thompson, Michael A

AU - et al, null

AU - Complex General Surgical Oncology Faculty, Aurora

N1 - Kumar S, Wei Z, Thompson MA, et al. ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation. Journal of clinical oncology. 2021;39:TPS8052-TPS8052.

PY - 2021/5/1

Y1 - 2021/5/1

UR - https://institutionalrepository.aah.org/surgoncfaculty/41

U2 - 10.1200/JCO.2021.39.15_suppl.TPS8052

DO - 10.1200/JCO.2021.39.15_suppl.TPS8052

M3 - Meeting abstract

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation

Access to Document

Other files and links

Cite this